Athanasios Tsiatis
Technik-/Wissenschafts-/F&E-Leiter bei ALX ONCOLOGY HOLDINGS INC.
Profil
Athanasios Tsiatis is currently the Senior Vice President-Clinical Development at ALX Oncology Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Plexxikon, Inc. from 2018 to 2021.
He completed his undergraduate degree at New York University and obtained his doctorate from Vanderbilt University School of Medicine.
Aktive Positionen von Athanasios Tsiatis
| Unternehmen | Position | Beginn |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
Ehemalige bekannte Positionen von Athanasios Tsiatis
| Unternehmen | Position | Ende |
|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
Ausbildung von Athanasios Tsiatis
| New York University | Undergraduate Degree |
| Vanderbilt University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Commercial Services |
